Refractory Lymphoma Clinical Trials in Xiamen, Fujian
2 recruitingXiamen, Fujian, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL
Non-Hodgkin LymphomaRefractory LymphomaChimeric Antigen Receptor T-cell
The First Affiliated Hospital of Xiamen University45 enrolled1 locationNCT06875063
Recruiting
Phase 2
Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma
LymphomaFollicular LymphomaRefractory Lymphoma
The First Affiliated Hospital of Xiamen University30 enrolled1 locationNCT06826118